US Funds Controversial Hepatitis B Vaccine Study in Guinea-Bissau Amid CDC Guideline Shift

December 19, 2025

US Funds Controversial Hepatitis B Vaccine Study in Guinea-Bissau Amid CDC Guideline Shift

The US plans to spend $1.6 million on a hepatitis B vaccine study in Guinea-Bissau, despite expert warnings of ethical risks. The move follows CDC changes making the birth vaccine an ‘individual decision’ and raises global health concerns.

Stone Tools from Middle Palaeolithic Era Found in Tamil Nadu’s Virudhunagar

December 19, 2025

Stone Tools from Middle Palaeolithic Era Found in Tamil Nadu’s Virudhunagar

A postgraduate student from the University of Madras found stone tools possibly from the Middle Palaeolithic period in Mallankinaru, Virudhunagar. Experts see this as a major archaeological discovery that could uncover more ancient artefacts with further study.

Arctic Rivers Turn Orange as Melting Permafrost Releases Metals in Alaska

December 19, 2025

Arctic Rivers Turn Orange as Melting Permafrost Releases Metals in Alaska

In northern Alaska, Arctic rivers have turned orange because melting permafrost releases metals like iron into the water. This natural process changes water chemistry and threatens aquatic life and local communities. Scientists warn this is a clear sign of climate change reshaping polar landscapes.

Indian Study Finds Common Drug Meclizine Can Boost TB Treatment by Targeting Immune Cell Metabolism

December 19, 2025

Indian Study Finds Common Drug Meclizine Can Boost TB Treatment by Targeting Immune Cell Metabolism

Researchers reveal that the common drug meclizine can reprogram immune cells to make tuberculosis bacteria more sensitive to antibiotics. This discovery could shorten TB treatment and reduce drug resistance.

Diabetes Cases to Hit 900 Million by 2050, Says International Diabetes Federation

December 19, 2025

Diabetes Cases to Hit 900 Million by 2050, Says International Diabetes Federation

The International Diabetes Federation's latest report forecasts a sharp rise in diabetes cases globally, from 500 million in 2024 to nearly 900 million by 2050. Urban areas and low to middle income countries will see most growth, with China and India leading in numbers.